Search | IOVS | ARVO Journals

View

Showing 1 – 11 of 11

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Inhibition of Laser–Induced Choroidal Neovascularization in Mice Using Antisense Oligonucleotides Directed Against HIF–1 or HIF–1ß

T.W. Lauer; S.F. Hackett; R. Formica; K. Yokoi; N.H. Khu; S. Henry; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1428. doi:

ARVO Annual Meeting Abstract May 2005

A VEGF121–Gelonin Fusion Protein (VEGF121/rGel) Induces Regression of Subretinal and Choroidal Neovascularization (CNV)

H. Akiyama; R.L. Silva; S. Kachi; N. Umeda; S. Aslam; S.F. Hackett; K. Mohamedali; M.G. Rosenblum; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):455. doi:

ARVO Annual Meeting Abstract May 2005

p66shc Regulates Redox–Sensitive NF–B Activation and Oxidative Stress–Induced Apoptosis in Human RPE Cells

Z. Wu; S.F. Hackett; S. Kachi; B. Rogers; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1615. doi:

ARVO Annual Meeting Abstract May 2005

Expression of a Constitutively Active Form of HIF–1 in Photoreceptors Causes Retinal and Subretinal Neovascularization

S.F. Hackett; T.W. Lauer; C.J. Weitz; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4192. doi:

ARVO Annual Meeting Abstract May 2005

Quantitative Assessment of Oxidative Damage in Cultured RPE Cells by Carbonyl ELISA

L. Lu; S.F. Hackett; A. Mincey; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5354. doi:

ARVO Annual Meeting Abstract May 2004

Increased Expression of VEGF in Retinal Pigmented Epithelial (RPE) Cells is Not Sufficient to Cause Choroidal Neovascularization (CNV)

Y. Oshima; S. Oshima; H. Nambu; S. Kachi; S.F. Hackett; M. Kaleko; S. Connelly; N. Esumi; D.J. Zack; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2229. doi:

ARVO Annual Meeting Abstract May 2004

Comparison of retinal thickness of mice retina with StratusOCT and histology.

S.M. Shah; R. Lima e Silva; Y. Saishin; S.F. Hackett; F. Woreta; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2375. doi:

ARVO Annual Meeting Abstract May 2004

Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) Plays an Important Role in the Development of Ocular Neovascularization (NV)

J. Shen; R. Samul; R.L. Silva; Y. Saishin; H. Liu; S.F. Hackett; R. Aitchison; P. Pavco; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):491. doi:

ARVO Annual Meeting Abstract May 2004

HIF–1 induced VEGF augments, but is not essential for normal retinal vascular development

S.A. Vinores; W.–H. Xiao; S.F. Hackett; H. Liu; P. Carmeliet; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):4652. doi:

ARVO Annual Meeting Abstract May 2003

Angiopoietin 1 (Ang1) Decreases Ocular Neovascularization (NV) and VEGF-Induced Breakdown of the Blood-Retinal Barrier (BRB)

H. Nambu; R. Nambu; Y. Oshima; E. Duh; S.F. Hackett; D.J. Zack; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):2901. doi:

ARVO Annual Meeting Abstract May 2003

Angiopoietin 2 (Ang2) Increases or Decreases Neovascularization (NV) Depending Upon the Setting

Y. Oshima; S. Oshima; K. Takahashi; H. Nambu; R.S. Apte; E. Duh; S.F. Hackett; D.J. Zack; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):4519. doi:

Advertisement